Asia Pacific Blood Glucose Monitoring Market  Research Report –Forecast till 2027

Asia Pacific Blood Glucose Monitoring Market Information: By Product Type (Invasive Glucose Monitoring, CGM, Flash Glucose Monitoring), Application (Type 1 Diabetes, Type 2 Diabetes), & End User (Diagnostic Centers, Hospitals, Clinics) - Forecast till 2027

ID: MRFR/MED/0189-HCR | February 2021 | Region: Global | 115 pages

Market Scenario


Blood glucose monitoring is the process of testing the glucose level in the blood. It helps to identify the blood glucose level within the specified target range. Thus, it helps to understand the food intake, exercise, insulin, and blood glucose level. The blood glucose monitoring devices provide useful information to manage diabetes. It helps to track the progress of treatment goal as well as monitor the effect of diabetes meditation on blood sugar level and understand the effect of illness and stress on the blood sugar level.


Various blood glucose monitoring devices are available in the market, which is referred as blood glucose meter. These device help to track the blood glucose level at home, clinics, hospitals, etc. Furthermore, they are designed to apply to the different type of diabetes.


The blood glucose monitoring devices market growth is majorly attributed to the increasing prevalence of diabetes,  developing technology for monitoring and diagnosis of diabetes, early detection of diabetes, and increasing demand for continuous glucose monitoring devices.


The Asia Pacific blood glucose monitoring devices market is expected to grow at a CAGR of 10% over the review period. China and India are potential market players owing to the largest diabetes patient population.


According to the Diabetes prevalence figures suggested by the Australian Bureau of Statistics, more than 5.1% of the Australian population diagnosed with diabetes in 2016.


However, as per the Centers for Disease Control and Prevention (CDC), the risk of transmitting hepatitis B virus (HBV) and other infection during assisted blood glucose monitoring and insulin administration is more.


Intended Audience



  • Diagnostic centers

  • Hospitals

  • Homecare Diagnostics

  • Clinics 


Figure: Asia Pacific Blood Glucose Monitoring Market, By Application Market Share, 2016 (%) Asia Pacific Blood Glucose Monitoring Market Sources: Annual reports, Press release, White paper, Company presentation


 Segmentations The Asia Pacific blood glucose monitoring devices market is segmented on the basis of product type, application, and end user


On the basis of the product type, it is segmented into invasive glucose monitoring devices, continuous glucose monitoring devices (CGM), flash glucose monitoring devices, and others.


On the basis of the application, it is segmented into type 1 diabetes, type 2 diabetes, and others.


On the basis of the end user, it is segmented into diagnostic centers, hospitals, clinics, research centers, and home care diagnostics.


Research Methodology


Asia Pacific Blood Glucose Monitoring Market-


Sources: Annual reports, Press release, White paper, and Company presentation


Regional Analysis China dominates the Asia Pacific blood glucose monitoring devices market owing to well-developed technology, increasing patient population with diabetes, high health care spending, and increasing government support for research & development. Furthermore, increased R&D activities and the concentration of major companies have fuelled the growth of the market in this region.


India holds the second position in the Asia Pacific blood glucose market owing to the government support for research & development and availability of funds for research. This is expected to continue driving the Indian market over the forecasted period. Moreover, countries like Japan, Australia, and the Republic of Korea are showing a considerable growth in the blood glucose monitoring market.


Asia Pacific is the fastest growing blood glucose monitoring market owing to the presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure. Moreover, increasing demand for new treatment methods in countries like India and South Korea is likely to emerge as the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare is projected to lead the demand for advanced equipment, which, in turn, may increase the market demand for the blood glucose monitoring devices in the region.


Key Players Some of key the players in the market are Abbott Laboratories, Arkay, Inc., Bayer Healthcare AG, F. Hoffmann-La Roche, Goldsite Diagnostics Inc., GlySure Ltd, Sphere Medical, Dexcom, Inc., and LifeScan. 


 



Table of Content
1. Report Prologue

2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

6. Asia Pacific Blood Glucose Monitoring Market, by Product Type

6.1 Introduction

6.2 Invasive Glucose Monitoring Devices

6.2.1 Market Estimates & Forecast, 2020-2027

6.3 Continuous Glucose Monitoring Devices

6.3.1 Market Estimates & Forecast, 2020-2027

6.4 Flash Glucose Monitoring Devices

6.4.1 Market Estimates & Forecast, 2020-2027

6.5 Others

7. Asia Pacific Blood Glucose Monitoring Market, by Application

7.1 Introduction

7.2 Type 1 Diabetes

7.2.1 Market Estimates & Forecast, 2020-2027

7.3 Type 2 Diabetes

7.3.1 Market Estimates & Forecast, 2020-2027

7.4 Others

7.4.1 Market Estimates & Forecast, 2020-2027

8. Asia Pacific Blood Glucose Monitoring Market, by End User

8.1 Introduction

8.2 Hospitals

8.2.1 Market Estimates & Forecast, 2020-2027

8.3 Diagnostic Centers

8.3.1 Market Estimates & Forecast, 2020-2027

8.4 Clinics

8.4.1 Market Estimates & Forecast, 2020-2027

8.5 Research centers

8.5.1 Market Estimates & Forecast, 2020-2027

8.6 Homecare Diagnostics

8.6.1 Market Estimates & Forecast, 2020-2027

9. Asia Pacific Blood Glucose Monitoring Market, by Region

9.1 Introduction

9.2 Japan

9.3 China

9.4 India

9.5 Republic of Korea

9.6 Australia

9.7 Rest of Asia Pacific

10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

11 Company Profiles

11.1 Abbott Laboratories

11.1.1 Company Overview

11.1.2 Product Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 Arkay, Inc.

11.2.1 Company Overview

11.2.2 Product Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Bayer Healthcare AG

11.3.1 Company Overview

11.3.2 Product Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 F. Hoffmann-La Roche

11.4.1 Company Overview

11.4.2 Product/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Goldsite Diagnostics Inc.

11.5.1 Company Overview

11.5.2 Product Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.6 GlySure Ltd

11.6.1 Company Overview

11.6.2 Product Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.7 Sphere Medical

11.7.1 Overview

11.7.2 Product Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Dexcom, Inc.

11.8.1 Overview

11.8.2 Product Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 LifeScan

11.9.1 Overview

11.9.2 Product Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Others

12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Pharmaceutical Industry

13 Appendix


LIST OF TABLES

Table 1 Blood glucose monitoring Industry Synopsis, 2020-2027

Table 2 Asia Pacific Blood glucose monitoring Market Estimates and Forecast, 2020-2027, (USD Million)

Table 3 Asia Pacific Blood glucose monitoring Market by Country, 2020-2027, (USD Million)

Table 4 Asia Pacific Blood glucose monitoring Market by Product Type, 2020-2027, (USD Million)

Table 5 Asia Pacific Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 6 Asia Pacific Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

Table 7 Japan Blood glucose monitoring Market by Types, 2020-2027, (USD Million)

Table 8 Japan Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 9 Japan Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

Table 10 China Blood glucose monitoring Market by Types, 2020-2027, (CHINAD Million)

Table 11 China Blood glucose monitoring Market by Application, 2020-2027, (CHINAD Million)

Table 12 China Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

Table 13 India Blood glucose monitoring Market by Types, 2020-2027, (USD Million)

Table 14 India Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 15 India Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

Table 16 Republic of Korea Blood glucose monitoring Market by Types, 2020-2027, (USD Million)

Table 17 Republic of Korea Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 18 Republic of Korea Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

Table 19 Australia Blood glucose monitoring Market by Types, 2020-2027, (USD Million)

Table 20 Australia Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 21 Australia Blood glucose monitoring Market by End User, 2020-2027, (USD Million)

Table 22 Rest of Asia Pacific Blood glucose monitoring Market by Types, 2020-2027, (USD Million)

Table 23 Rest of Asia Pacific Blood glucose monitoring Market by Application, 2020-2027, (USD Million)

Table 24 Rest of Asia Pacific Blood glucose monitoring Market by End User, 2020-2027, (USD Million)


LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Asia Pacific Blood Glucose Monitoring Market

Figure 3 Segmentation Market Dynamics for Blood Glucose Monitoring Market

Figure 4 Asia Pacific Blood Glucose Monitoring Market Share, by Product Type 2020

Figure 5 Asia Pacific Blood Glucose Monitoring Market Share, by Application 2020

Figure 6 Asia Pacific Blood Glucose Monitoring Market Share, by End User, 2020

Figure 7 Asia Pacific Blood Glucose Monitoring Market Share, by Country, 2020

Figure 8 Asia Pacific Blood Glucose Monitoring Market: Company Share Analysis, 2020 (%)

Figure 9 Abbott Laboratories.: Key Financials

Figure 10 Abbott Laboratories.: Segmental Revenue

Figure 11 Abbott Laboratories.: Geographical Revenue

Figure 12 Arkay, Inc.: Key Financials

Figure 13 Arkay, Inc.: Segmental Revenue

Figure 14 Arkay, Inc.: Geographical Revenue

Figure 15 Bayer Healthcare AG: Key Financials

Figure 16 Bayer Healthcare AG: Segmental Revenue

Figure 17 Bayer Healthcare AG: Geographical Revenue

Figure 18 F. Hoffmann-La Roche: Key Financials

Figure 19 F. Hoffmann-La Roche: Segmental Revenue

Figure 20 F. Hoffmann-La Roche: Geographical Revenue

Figure 21 Goldsite Diagnostics Inc.: Key Financials

Figure 22 Goldsite Diagnostics Inc.: Segmental Revenue

Figure 23 Goldsite Diagnostics Inc.: Geographical Revenue

Figure 24 GlySure Ltd: Key Financials

Figure 25 GlySure Ltd: Segmental Revenue

Figure 26 GlySure Ltd: Geographical Revenue

Figure 27 Sphere Medical: Key Financials

Figure 28 Sphere Medical: Segmental Revenue

Figure 29 Sphere Medical: Geographical Revenue

Figure 30 Dexcom, Inc.: Key Financials

Figure 31 Dexcom, Inc.: Segmental Revenue

Figure 32 Dexcom, Inc.: Geographical Revenue

Figure 33 LifeScan: Key Financials

Figure 34 LifeScan: Segmental Revenue

Figure 35 LifeScan: Geographical Revenue